HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Pantethine, diabetes mellitus and atherosclerosis. Clinical study of 1045 patients].

Abstract
After a review of the clinical studies on the treatment of diabetic patients with pantethine, the authors discuss the results obtained in a postmarketing surveillance (PMS) study on 1045 hyperlipidemic patients receiving pantethine (900 mg/day on average). Of these patients, 57 were insulin-dependent (Type I) and 241 were non insulin-dependent (Type II) diabetics. Beyond the epidemiological considerations made possible by a PMS study, the authors show that pantethine brought about a statistically significant and comparable improvement of lipid metabolism in the three groups of patients, with very good tolerability. Pantethine should therefore be considered for the treatment of lipid abnormalities also in patients at risk such as those with diabetes mellitus.
AuthorsC Donati, R S Bertieri, G Barbi
JournalLa Clinica terapeutica (Clin Ter) Vol. 128 Issue 6 Pg. 411-22 (Mar 31 1989) ISSN: 0009-9074 [Print] Italy
Vernacular TitlePantetina, diabete e aterosclerosi. Indagine clinica su 1045 pazienti.
PMID2524328 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Sulfhydryl Compounds
  • Pantetheine
  • pantethine
Topics
  • Arteriosclerosis (etiology, prevention & control)
  • Diabetes Mellitus (blood, drug therapy)
  • Diabetes Mellitus, Type 1 (blood, drug therapy)
  • Diabetes Mellitus, Type 2 (blood, drug therapy)
  • Female
  • Humans
  • Hyperlipoproteinemias (blood, drug therapy)
  • Male
  • Middle Aged
  • Pantetheine (analogs & derivatives, therapeutic use)
  • Product Surveillance, Postmarketing
  • Sulfhydryl Compounds (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: